Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.
Authors
Fotouhi, OKjellin, H
Larsson, C
Hashemi, J
Barriuso, J
Juhlin, C
Lu, M
Höög, A
Pastrián, L
Lamarca, Angela
Soto, V
Zedenius, J
Mendiola, M
Lehtiö, J
Kjellman, M
Affiliation
Department of Oncology-Pathology Karolinska Institutet, StockholmIssue Date
2016-10
Metadata
Show full item recordAbstract
Somatostatin analogs are established in the treatment of neuroendocrine tumors (NETs) including small intestinal NET; however, the molecular mechanisms are not well known. Here, we examined the direct effects of lanreotide in NET cell line models.Citation
Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors. 2016, 101 (10):3616-3627 J Clin Endocrinol MetabJournal
The Journal of Clinical Endocrinology and MetabolismDOI
10.1210/jc.2016-2028PubMed ID
27459532Type
ArticleLanguage
enISSN
1945-7197ae974a485f413a2113503eed53cd6c53
10.1210/jc.2016-2028
Scopus Count
Collections
Related articles
- Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines.
- Authors: Kidd M, Drozdov I, Joseph R, Pfragner R, Culler M, Modlin I
- Issue date: 2008 Aug 15
- Lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors.
- Authors: Saif MW
- Issue date: 2016
- Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells.
- Authors: Krug S, Mordhorst JP, Moser F, Theuerkorn K, Ruffert C, Egidi M, Rinke A, Gress TM, Michl P
- Issue date: 2019
- The safety of lanreotide for neuroendocrine tumor.
- Authors: Godara A, Siddiqui NS, Byrne MM, Saif MW
- Issue date: 2019 Jan
- Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors.
- Authors: Palazzo M, Lombard-Bohas C, Cadiot G, Matysiak-Budnik T, Rebours V, Vullierme MP, Couvelard A, Hentic O, Ruszniewski P
- Issue date: 2013 Feb